apollo
logo
0Login
Introducing Our Latest Arrival!
Taficita 200/25 mg Tablet 30's

Taficita 200/25 mg Tablet 30's

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Mylan Pharmaceuticals Pvt Ltd

Consume Type

ORAL

Return Policy

Not Returnable

for this medicine

About Taficita 200/25 mg Tablet 30's

Taficita 200/25 mg Tablet 30's belongs to a group of antiretroviral medicines used to treat HIV infection. Taficita 200/25 mg Tablet 30's helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illness such as cancer or serious infections. Taficita 200/25 mg Tablet 30's also helps in reducing the risk of getting HIV-1 infection when used as a daily treatment along with practising safe sex.
 
Taficita 200/25 mg Tablet 30's is a combination of two drugs, namely: Emtricitabine and Tenofovir disoproxil. Emtricitabine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. Taficita 200/25 mg Tablet 30's works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Together, Taficita 200/25 mg Tablet 30's helps in treating HIV infection.
 
You are advised to take Taficita 200/25 mg Tablet 30's for as long as your doctor has prescribed it for you depending on your medical condition. In some cases, Taficita 200/25 mg Tablet 30's may cause certain common side-effects such as headache, dizziness, nausea, vomiting, diarrhoea, weakness, and rash. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
 
Practise safe sex and take necessary precautions, as Taficita 200/25 mg Tablet 30's does not prevent the spread of HIV infection. Consult your doctor if you are pregnant or planning for pregnancy. Avoid breastfeeding while taking Taficita 200/25 mg Tablet 30's. Taficita 200/25 mg Tablet 30's may cause dizziness, so drive with caution. Taficita 200/25 mg Tablet 30's is not recommended for children below 12 years. Keep your doctor informed about your health condition and the medicines you are taking to prevent any side-effects/interactions.

Uses of Taficita 200/25 mg Tablet 30's

Treatment of HIV infection

Medicinal Benefits

Taficita 200/25 mg Tablet 30's belongs to a group of antiretroviral medicines used to treat HIV infection. Taficita 200/25 mg Tablet 30's helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illnesses such as cancer or serious infections. Taficita 200/25 mg Tablet 30's is a combination of two drugs, namely: Emtricitabine and Tenofovir disoproxil. Emtricitabine is a nucleoside reverse transcriptase inhibitor, whereas Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor. Taficita 200/25 mg Tablet 30's works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Together, Taficita 200/25 mg Tablet 30's helps in treating HIV infection. Taking Taficita 200/25 mg Tablet 30's along with practising safe sex and lifestyle changes may reduce the risk of getting or transmitting the HIV virus to others. 

Directions for Use

Take Taficita 200/25 mg Tablet 30's with food. Swallow Taficita 200/25 mg Tablet 30's as a whole with water; do not chew or crush it.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Taficita 200/25 mg Tablet 30's

  • Headache
  • Dizziness
  • Nausea
  • Vomiting
  • Diarrhoea
  • Weakness
  • Rash

Drug Warnings

Do not take Taficita 200/25 mg Tablet 30's if you are allergic to any of its contents. Inform your doctor if you have a history of hepatitis B infection, kidney or liver problems or if you are older than 65 years. Regularly get blood and urine tests done while taking Taficita 200/25 mg Tablet 30's. Practise safe sex and take other necessary precautions as Taficita 200/25 mg Tablet 30's does not prevent the spread of HIV infection. Consult your doctor if you are pregnant or planning for pregnancy. Avoid breastfeeding while taking Taficita 200/25 mg Tablet 30's. Taficita 200/25 mg Tablet 30's may cause dizziness, so drive with caution. Taficita 200/25 mg Tablet 30's is not recommended for children below 12 years. Talk to your doctor immediately if you notice any signs or symptoms of infection or inflammation.

Drug Interactions

Drug-Drug Interactions: Taficita 200/25 mg Tablet 30's may interact with anti-HIV (ritonavir, darunavir), anti-fungal (amphotericin B), anti-viral (foscarnet, ganciclovir, cidofovir), antimicrobial (pentamidine), antibiotic (vancomycin), anti-cancer (interleukin-2).

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: No interactions found/established.

Drug-Drug Interactions Checker List

  • AMPHOTERICIN B
  • FOSCARNET
  • GANCICLOVIR
  • PENTAMIDINE
  • VANCOMYCIN
  • INTERLEUKIN-2
  • CIDOFOVIR
  • RITONAVIR
  • DARUNAVIR

Habit Forming

No

Diet & Lifestyle Advise

  • Practise safe sex by using condoms; it helps in reducing contact with semen and vaginal fluids.
  • Never share personal items with body fluids or blood on them, such as razor blades or toothbrushes.
  • Avoid sharing used needles, other injection or drug equipment.
  • Get tested for other sexually transmitted infections, such as gonorrhoea or syphilis.
  • Eat a healthy and balanced diet. Eat vitamin and nutrient-rich food such as vegetables and fruits as it helps to boost your immune system. Opt for lean protein and whole grains.
  • Avoid eating raw meat and eggs. Consume properly boiled and cooked meat, poultry or seafood.
  • Eat bland and low-fat foods, and avoid spicy or oily foods if you experience nausea or vomiting.
  • Try to reduce emotional and physical stress by spending time with family or do whatever makes you happy.

Special Advise

  • Get HIV test done for at least every 3 months.
  • Regular kidney and liver function tests, bone mineral density test while taking Taficita 200/25 mg Tablet 30's is advised. 
  • Taficita 200/25 mg Tablet 30's might affect laboratory test results, inform the person doing the tests that you are taking Taficita 200/25 mg Tablet 30's.

Disease/Condition Glossary

HIV infection: HIV (Human Immunodeficiency Virus) is a virus that attacks the immune system and destroys the white blood cells that help in fighting infection, making the individual susceptible to other infections or illnesses. People with HIV experience flu-like symptoms such as fever, chills, rash, night sweats, muscle aches, tiredness, and sore throat. These symptoms usually last for days to several weeks. HIV spreads through body fluids such as semen, vaginal fluid, and blood. If left untreated, this condition can lead to AIDS (Acquired Immunodeficiency Syndrome). It is a life-long condition, and there is no definite cure for it. However, it can be controlled by treating it with antiretroviral drugs. 

bannner image

Alcohol

Caution

It is not known whether alcohol interacts with Taficita 200/25 mg Tablet 30's. Please consult your doctor.

bannner image

Pregnancy

Caution

Please consult your doctor if you are pregnant; your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Breast Feeding

Unsafe

Avoid breastfeeding while taking Taficita 200/25 mg Tablet 30's as it may pass into breastmilk.

bannner image

Driving

Caution

Taficita 200/25 mg Tablet 30's may cause dizziness. So, drive or operate machinery only if you are alert.

bannner image

Liver

Caution

Dose adjustment may be needed. Please consult your doctor before taking Taficita 200/25 mg Tablet 30's if you have a liver impairment or any concerns regarding this.

bannner image

Kidney

Caution

Dose adjustment may be needed. Please consult your doctor before taking Taficita 200/25 mg Tablet 30's if you have kidney impairment or any concerns regarding this.

bannner image

Children

Unsafe

Taficita 200/25 mg Tablet 30's is not recommended for children below 12years.

Country of origin

India

Manufacturer/Marketer address

Mylan Pharmaceuticals Private Limited , Commercial Operations , Prestige Tech Park,Platina-3, 7Th To 12Th Floor, Prestige Tech Park, Kadubesanahalli, Bangalore -560103.
Other Info - TAF0021

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Taficita 200/25 mg Tablet 30's is used to treat HIV infection. It helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illnesses such as cancer or serious infections.
Taficita 200/25 mg Tablet 30's contains Emtricitabine and Tenofovir disoproxil. Taficita 200/25 mg Tablet 30's works by interfering with the working of nucleotide and nucleoside reverse transcriptase enzymes which are necessary for the reproduction of the virus. Thereby, Taficita 200/25 mg Tablet 30's helps in treating HIV infection.
Do not stop taking Taficita 200/25 mg Tablet 30's without consulting your doctor as it may reduce the effectiveness of anti-HIV therapy. Continue taking Taficita 200/25 mg Tablet 30's for as long as your doctor has prescribed it. Do not be reluctant to speak with your doctor if you experience any difficulty while taking Taficita 200/25 mg Tablet 30's.
Taficita 200/25 mg Tablet 30's might cause lactic acidosis (excess of lactic acid in the blood), a rare but a severe side effect, especially in women who are obese and people with liver disease. Consult a doctor immediately if you experience stomach pain, vomiting, nausea, drowsiness, and deep rapid breathing while taking Taficita 200/25 mg Tablet 30's.
Taficita 200/25 mg Tablet 30's does not cure HIV infection. However, Taficita 200/25 mg Tablet 30's helps in decreasing the chance of developing AIDS (acquired immunodeficiency syndrome) and other HIV-related illnesses such as cancer or serious infections.
Taficita 200/25 mg Tablet 30's can be taken by HIV-negative patients to lower the chance of getting HIV infection if prescribed by the doctor. Before starting the treatment, you should have a negative HIV test. Whilst taking Taficita 200/25 mg Tablet 30's regular HIV tests for at least every 3 months is advised.
Taficita 200/25 mg Tablet 30's may cause bone problems such as soft bones, thin bones, and bone pain. Regular bone density test is advised while taking Taficita 200/25 mg Tablet 30's. For good bone health, take calcium and vitamin D supplements as advised by the doctor.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.